INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 26 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $84,276 | +68.9% | 86,000 | +68.6% | 0.00% | – |
| Q4 2022 | $49,888 | +3.9% | 51,000 | +2.0% | 0.00% | – |
| Q3 2022 | $48,000 | 0.0% | 50,000 | 0.0% | 0.00% | – |
| Q2 2022 | $48,000 | +2.1% | 50,000 | 0.0% | 0.00% | – |
| Q1 2022 | $47,000 | -2.1% | 50,000 | 0.0% | 0.00% | – |
| Q4 2021 | $48,000 | +77.8% | 50,000 | +66.7% | 0.00% | – |
| Q3 2021 | $27,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|